Wooree Group is calling for greater scientific validation in the rapidly expanding liposome market, arguing that clearer quality standards could become increasingly important as ingredient suppliers and nutraceutical brands compete on delivery technology and product claims.

The biotechnology and lighting company made the case during Vitafoods Asia 2026, held September 2–4 in Bangkok, where it presented its liposome technology and vertically integrated bio portfolio. The company participated in the event for the second consecutive year, bringing together ingredient developer Wooree Green Science, manufacturer Wooree Bio and consumer brands Harutin and Clarion.

At the center of the company's presentation was a proposed six-part framework for validating liposomal products. CEO Ji-yong Yoon argued that the presence of phospholipids or a measured particle size should not, by itself, establish that a product qualifies as a meaningful liposomal formulation.

The proposed framework includes Cryo-TEM-based liposome structure verification, nanoparticle tracking analysis (NTA), encapsulation efficiency, long-term shelf stability, gastrointestinal stability and pharmacokinetic evaluation of bioavailability.

Market Landscape

The push for validation comes as supplement and functional-ingredient companies increasingly position delivery systems as a differentiator. Liposomal formulations are marketed around the potential to improve the delivery or absorption of active ingredients, creating a competitive environment in which technical claims can become an important part of product positioning.

Wooree's approach places analytical evidence at the center of that positioning. The company says its LIPOPRIME ingredient portfolio now includes approximately 40 ingredients, spanning Vitamin C, glutathione, omega-3 and curcumin.

Wooree Green Science also reported that NTA testing of selected LIPOPRIME ingredients showed particle concentrations up to 24 times higher than competing market alternatives. Because the company itself supplied the comparison, the figure should be viewed as a company-reported result rather than an independent industry benchmark.

The broader issue is how nutraceutical marketers can translate complex formulation science into credible consumer-facing claims. Greater standardization could potentially make it easier for manufacturers, distributors and buyers to distinguish between formulations based on documented performance rather than terminology alone.

Strategic Outlook

For Wooree, scientific validation is also becoming part of its broader international growth strategy. The company has introduced test products from Harutin on Amazon in the United States and is collaborating with a plant-cell biotechnology company on next-generation functional ingredients.

Its proposed validation model could therefore serve both a technical and commercial purpose. If adopted more broadly, standardized testing could give ingredient suppliers additional evidence for product differentiation while helping downstream brands build more defensible marketing narratives.

However, validation alone does not establish consumer demand or clinical effectiveness. The six pillars proposed by Wooree should be viewed as the company's suggested framework rather than an established industry standard.

Top Insights

1. Scientific validation is becoming a marketing differentiator in technology-led nutraceutical categories.
2. Liposome claims face a standardization challenge, according to Wooree Group.
3. NTA and structural testing are positioned as key components of the company's proposed framework.
4. LIPOPRIME covers approximately 40 ingredients, according to Wooree.
5. Global expansion is becoming a strategic priority, with activity in the U.S. and Southeast Asia.

Get in touch with our MarTech Experts.